C. Fulignati - Concepedia

Author

C. Fulignati

Also Known As

C Fulignati, C. FULIGNATI, C. Fulignati, Chiara Fulignati

Publications

126

Citations

H-Index

Concepts

All Affiliations

C. Fulignati is an author at University of Florence specializing in medicine, cancer therapeutics, and clinical trials.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	25
2	Cancer Therapeutics	2	2	25
3	Health Sciences	1	1	10
4	Immunology	1	1	10
5	Pharmacology	1	1	15

C. Fulignati

Publications

119

Citations

H-Index

Page 1

	Year	Citations
Phase II Trial of Weekly Intravenous Gemcitabine Administration With Interferon and Interleukin-2 Immunotherapy for Metastatic Renal Cell Cancer B Neri, Laura Doni, M T Gemelli, The Journal of Urology	2002	27
Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: a multicenter phase II study B Neri, G Cini, Laura Doni, British Journal of Cancer	2002	24
Raltitrexed plus oxaliplatin as first-line chemotherapy in metastatic colorectal carcinoma: a multicentric phase II trial B Neri, Laura Doni, C. Fulignati, Anti-Cancer Drugs	2002	21
Gemcitabine plus Epi-doxorubicin as first-line chemotherapy for bladder cancer in advanced or metastatic stage: a phase II. B Neri, Laura Doni, C. Fulignati, PubMed UrologyOncologyImproved Response RateGenitourinary CancerMedicine	2003	15
An uncommon clinical presentation of retroperitoneal non-Hodgkin lymphoma successfully treated with chemotherapy: A case report C. Fulignati World Journal of Gastroenterology	2005	12
Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma: report of a phase II trial B Neri, Gianluca Cipriani, C. Fulignati, Anti-Cancer Drugs	2004	10
Long-Term Survival in Metastatic Melanoma Patients Treated with Sequential Biochemotherapy: Report of a Phase II Study B Neri, Lorenzo Vannozzi, C. Fulignati, Cancer Investigation ImmunologyPhase Ii StudyLong-term SurvivalPharmacotherapyMalignant Melanoma	2006	10

Page 1